Latest 13F Filing: Ameriprise Financial, Inc.'s Top Buys and Sells.
Ameriprise Financial, Inc., a diversified financial services company, operates through five key segments: Advice & Wealth Management, Asset Management, Annuities, Protection, and Corporate & Other. The company, which primarily functions via its subsidiaries, had over 9,700 affiliated advisors as of December 31, 2012.
In the U.S., Ameriprise operates under three main brands: Ameriprise Financial, Columbia Management, and RiverSource, while the Threadneedle brand represents its international asset management products.
Ameriprise Financial, Inc. filed its most recent 13F on 22 May 2023, for the quarter ended 31 Mar 2023.
Drawing on the data and insights gathered via Radient, the focus now turns to significant highlights, equity transactions, and sales at Ameriprise Financial, Inc for Q1 2023, as reported in their most recent 13F filing.
The firm disclosed 304.95 B in assets with a turnover rate of 10%. It holds 3933 securities in its 13F portfolio, and the top 10 holdings account for 14.3% of the portfolio.
Ameriprise Financial's top 3 holdings include Microsoft Corp ($10.51B), Apple Inc ($8.40B), Alphabet Inc-Cl A ($5.93B)
In a recent development, Ameriprise Financial Inc has made significant investments across several notable firms as of March 2023. These investments reflect their continued interest in prominent tech and retail companies, along with other sectors.
In the tech realm, Ameriprise augmented its holdings in Microsoft Corp by 0.30%, carrying the total investment value to $10.52 billion. Alphabet Inc- Class A saw a rise of 5.18% in Ameriprise's portfolio, boosting the value to $3.95 billion.
Ameriprise's interest in Amazon.com Inc also rose modestly by 0.44%, marking the investment at $3.79 billion. Their investment in Tesla Inc swelled by 6.91%, standing at $1.11 billion. Additionally, Ameriprise escalated its stakes in Qualcomm Inc by 14.26%, setting its holdings at $1.89 billion.
Turning to retail, Ameriprise amplified its investment in Walmart Inc by a significant 32.71%, taking the total investment to about $1.51 billion.
The tech industry further appealed to Ameriprise with augmented investments in Palo Alto Networks Inc and Analog Devices Inc. Their stakes in these companies ascended by 17.81% and 3.56% respectively, placing the investments at $988.72 million and $1.73 billion.
Furthermore, Ameriprise substantially increased its investment in Lam Research Corp by 12.70%, taking the total investment value to $2.98 billion.
In the healthcare sector, the company decreased its stake in Johnson & Johnson by 14.57%, lowering the total value to $2.31 billion. Similarly, Ameriprise's holdings in UnitedHealth Group Inc also saw a reduction of 22.36%, carrying the investment's value down to $1.51 billion.
Abbott Laboratories was another health-oriented firm where Ameriprise Financial scaled back its holdings by 22.24%, bringing the investment's value to $1.19 billion.
Turning to the retail sector, Ameriprise Financial trimmed its interest in Home Depot Inc by 16.22%, bringing the total investment value to $1.81 billion.
The financial sector witnessed a significant sell-off, with Ameriprise reducing its stake in US Bancorp by 79.96%, thereby reducing its investment to $116.69 million.
In the energy sector, Ameriprise Financial slashed its holdings in ConocoPhillips by 32.26%, dropping the total investment value to $761.13 million.
Ameriprise Financial also decided to lessen its stake in CVS Health Corp by 24.63%, resulting in an investment value of $639.68 million.
Among its investments in exchange-traded funds, Ameriprise scaled down its holdings in iShares iBoxx Investment Grade Corporate Bond ETF by 34.18%, putting the investment value at $898.13 million.
Likewise, the firm substantially reduced its stake in iShares MSCI EAFE ETF by 76.36%, leaving the remaining investment valued at $128.64 million.